Biblio

Export 794 results:
Author Title Type Year
Filters: Keyword is Humans  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
Humans
Y. Moon, Han, S. - H., and Moon, W. - J., Patterns of Brain Iron Accumulation in Vascular Dementia and Alzheimer's Dementia Using Quantitative Susceptibility Mapping Imaging., J Alzheimers Dis, vol. 51, no. 3, pp. 737-45, 2016.
M. T. White, Shaw, L. M., and Xie, S. X., Evaluation of Cerebrospinal Fluid Assay Variability in Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 2, pp. 463-70, 2016.
C. Hyoung Lyoo, Cho, H., Choi, J. Yong, Hwang, M. Song, Hong, S. Kyoon, Kim, Y. Joong, Ryu, Y. Hoon, and Lee, M. Sik, Tau Accumulation in Primary Motor Cortex of Variant Alzheimer's Disease with Spastic Paraparesis., J Alzheimers Dis, vol. 51, no. 3, pp. 671-5, 2016.
A. S. R. Sierksma, de Nijs, L., Hoogland, G., Vanmierlo, T., van Leeuwen, F. W., Rutten, B. P. F., Steinbusch, H. W. M., Prickaerts, J., and van den Hove, D. L. A., Fluoxetine Treatment Induces Seizure Behavior and Premature Death in APPswe/PS1dE9 Mice., J Alzheimers Dis, vol. 51, no. 3, pp. 677-82, 2016.
K. A. Southam, Vincent, A. J., and Small, D. H., Do Microglia Default on Network Maintenance in Alzheimer's Disease?, J Alzheimers Dis, vol. 51, no. 3, pp. 657-69, 2016.
L. Grangeon, Paquet, C., Bombois, S., Quillard-Muraine, M., Martinaud, O., Bourre, B., Lefaucheur, R., Nicolas, G., Dumurgier, J., Gerardin, E., Jan, M., Laplanche, J. - L., Peoc'h, K., Hugon, J., Pasquier, F., Maltête, D., Hannequin, D., and Wallon, D., Differential Diagnosis of Dementia with High Levels of Cerebrospinal Fluid Tau Protein., J Alzheimers Dis, vol. 51, no. 3, pp. 905-13, 2016.
G. Lou, Zhang, Q., Xiao, F., Xiang, Q., Su, Z., and Huang, Y., Intranasal TAT-haFGF Improves Cognition and Amyloid-β Pathology in an AβPP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 985-90, 2016.
M. Bocchetta, Mega, A., Bernardi, L., Di Maria, E., Benussi, L., Binetti, G., Borroni, B., Colao, R., Di Fede, G., Fostinelli, S., Galimberti, D., Gennarelli, M., Ghidoni, R., Piaceri, I., Pievani, M., Porteri, C., Redaelli, V., Rossi, G., Suardi, S., Babiloni, C., Scarpini, E., Tagliavini, F., Padovani, A., Nacmias, B., Sorbi, S., Frisoni, G. B., and Bruni, A. C., Genetic Counseling and Testing for Alzheimer's Disease and Frontotemporal Lobar Degeneration: An Italian Consensus Protocol., J Alzheimers Dis, vol. 51, no. 1, pp. 277-91, 2016.
S. K. Singhrao, Harding, A., Chukkapalli, S., Olsen, I., Kesavalu, L., and Crean, S. J., Apolipoprotein E Related Co-Morbidities and Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 935-48, 2016.
C. Rattanabannakit, Risacher, S. L., Gao, S., Lane, K. A., Brown, S. A., McDonald, B. C., Unverzagt, F. W., Apostolova, L. G., Saykin, A. J., and Farlow, M. R., The Cognitive Change Index as a Measure of Self and Informant Perception of Cognitive Decline: Relation to Neuropsychological Tests., J Alzheimers Dis, vol. 51, no. 4, pp. 1145-55, 2016.
M. Elahi, Hasan, Z., Motoi, Y., Matsumoto, S. - E., Ishiguro, K., and Hattori, N., Region-Specific Vulnerability to Oxidative Stress, Neuroinflammation, and Tau Hyperphosphorylation in Experimental Diabetes Mellitus Mice., J Alzheimers Dis, vol. 51, no. 4, pp. 1209-24, 2016.
D. Andriuta, Moullart, V., Schraen, S., Devendeville, A., Meyer, M. - E., and Godefroy, O., What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects?, J Alzheimers Dis, vol. 51, no. 3, pp. 793-800, 2016.
B. Ongali, Nicolakakis, N., Tong, X. - K., Aboulkassim, T., Imboden, H., and Hamel, E., Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1183-95, 2016.
J. de Pedro-Cuesta, Martínez-Martín, P., Rábano, A., Alcalde-Cabero, E., López, F. José Garc, Almazán-Isla, J., Ruiz-Tovar, M., Medrano, M. - J., Avellanal, F., Calero, O., and Calero, M., Drivers: A Biologically Contextualized, Cross-Inferential View of the Epidemiology of Neurodegenerative Disorders., J Alzheimers Dis, vol. 51, no. 4, pp. 1003-22, 2016.
R. Sánchez-Valle, Monté, G. C., Sala-Llonch, R., Bosch, B., Fortea, J., Lladó, A., Antonell, A., Balasa, M., Bargalló, N., and Molinuevo, J. Luis, White Matter Abnormalities Track Disease Progression in PSEN1 Autosomal Dominant Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 3, pp. 827-35, 2016.
Y. Ling Chai, Yeo, H. Kai- Hui, Wang, J., Hilal, S., Ikram, M. Kamran, Venketasubramanian, N., Wong, B. - S., and Chen, C. Li- Hsian, Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort., J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
Q. Yao, Jiang, G. - X., Zhou, Z. - M., Chen, J. - M., and Cheng, Q., Metabolic Syndrome and Mild Cognitive Impairment: A Case-Control Study among Elderly in a Shanghai Suburb., J Alzheimers Dis, vol. 51, no. 4, pp. 1175-82, 2016.
F. Guillot, Kemppainen, S., Lavasseur, G., Miettinen, P. O., Laroche, S., Tanila, H., and Davis, S., Brain-Specific Basal and Novelty-Induced Alternations in PI3K-Akt and MAPK/ERK Signaling in a Middle-Aged AβPP/PS1 Mouse Model of Alzheimer's Disease., J Alzheimers Dis, vol. 51, no. 4, pp. 1157-73, 2016.
R. Migliaccio, Gallea, C., Kas, A., Perlbarg, V., Samri, D., Trotta, L., Michon, A., Lacomblez, L., Dubois, B., Lehéricy, S., and Bartolomeo, P., Functional Connectivity of Ventral and Dorsal Visual Streams in Posterior Cortical Atrophy., J Alzheimers Dis, vol. 51, no. 4, pp. 1119-30, 2016.
N. R. Barthélemy, Gabelle, A., Hirtz, C., Fenaille, F., Sergeant, N., Schraen-Maschke, S., Vialaret, J., Buée, L., Junot, C., Becher, F., and Lehmann, S., Differential Mass Spectrometry Profiles of Tau Protein in the Cerebrospinal Fluid of Patients with Alzheimer's Disease, Progressive Supranuclear Palsy, and Dementia with Lewy Bodies., J Alzheimers Dis, vol. 51, no. 4, pp. 1033-43, 2016.
Y. Kim, Kim, C., Jang, H. Young, and Mook-Jung, I., Inhibition of Cholesterol Biosynthesis Reduces γ-Secretase Activity and Amyloid-β Generation., J Alzheimers Dis, vol. 51, no. 4, pp. 1057-68, 2016.
P. Adam, Křížková, S., Heger, Z., Babula, P., Pekařík, V., Vaculovičoá, M., Gomes, C. M., Kizek, R., and Adam, V., Metallothioneins in Prion- and Amyloid-Related Diseases., J Alzheimers Dis, vol. 51, no. 3, pp. 637-56, 2016.
L. Xu, Wu, X., Li, R., Chen, K., Long, Z., Zhang, J., Guo, X., and Yao, L., Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers., J Alzheimers Dis, vol. 51, no. 4, pp. 1045-56, 2016.
S. Wong, Bertoux, M., Savage, G., Hodges, J. R., Piguet, O., and Hornberger, M., Comparison of Prefrontal Atrophy and Episodic Memory Performance in Dysexecutive Alzheimer's Disease and Behavioral-Variant Frontotemporal Dementia., J Alzheimers Dis, vol. 51, no. 3, pp. 889-903, 2016.
K. Sakai, Senda, T., Hata, R., Kuroda, M., Hasegawa, M., Kato, M., Abe, M., Kawaguchi, K., Nakai, S., Hiki, Y., Yuzawa, Y., and Kitaguchi, N., Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid., J Alzheimers Dis, vol. 51, no. 4, pp. 997-1002, 2016.

Pages